Facebook Pixel Code

Concord Biotech Ltd. Share Price

NSE
BSE

CONCORD BIOTECH LTD.

Sector : Pharmaceuticals | Smallcap | BSE

Concord Biotech Ltd., operating in the Pharmaceuticals sector and classified as a Smallcap on the bse, currently has its share price at 1707 The stock has experienced fluctuations today, with a low of ₹1599 and a high of ₹1810.05 Over the past 52 weeks, the shares have seen a low of ₹952.05 and a high of ₹1793.5.

In terms of performance, Concord Biotech Ltd. has shown a return of 5.5% in one day, 0.97% over the past month, and 17.39% in the last three months.

Analyzing the technicals, the daily pivot level for the stock is set at 1700.9. The resistance levels are identified as R1 at 1802.8, R2 at 1911.95, and R3 at 2013.85. On the support side, the levels are marked as S1 at 1591.75, S2 at 1489.85, and S3 at 1380.7.

In the realm of technical analysis for our subject stock, the moving averages present a detailed picture. Over a short span of 5 days, the Simple Moving Average (SMA) stands at 1628.84, while the Exponential Moving Average (EMA) is noted at 1610.09. Extending the view to a 10-day period, the SMA adjusts to 1596.4 with the EMA slightly differing at 1608.33.

In a comparative analysis of stock performance within its sector, Concord Biotech Ltd. stands alongside several key competitors, each showcasing varied performance metrics over different time periods. Concord Biotech Ltd. itself has recorded performance figures of 1W % is 6.01 over the past week, 0.45% in the last month, and 16.78% over the past three months. Its six-month, one-year, three-year, and five-year performances are 6 month % is 16.2, 1yr % is 74.65, 3Y % is 79.82, and 5Y % is 79.82 respectively.

Read More  

₹1,707.00
5.7993.35
As on Aug 29, 2024, 2:34 PM | IST
Intraday
1 Week
1 Month
3 Months
6 Months
1 Year

Concord Biotech Ltd. Performance

Today's LowToday's High
₹1,599.00₹1,810.05
₹1,707.00
52 Weeks' Low52 Weeks' High
₹952.05₹1,793.50
₹1,707.00
Open Price
₹1,615.35
Prev. Close
₹1,613.65
Volume
78,961

Concord Biotech Ltd. Technicals

Pivot Level

  • R11,802.8
  • R21,911.95
  • R32,013.85
  • Pivot
    1,700.9
  • S11,591.75
  • S21,489.85
  • S31,380.7

Moving Average

  • DaySMAEMA
  • 51,628.841,610.09
  • 101,596.41,608.33
  • 201,603.081,609.03
  • 501,610.481,596.96
  • 1001,563.71,554.41
  • 2001,482.51,449.92

Concord Biotech Ltd. Peer Comparision

Stock Performance
Ratio Performance
Name
1W%
1M%
3M%
6M%
1Y%
3Y%
5Y%
6.010.4516.7816.2074.6579.8279.82
3.344.9222.3714.7762.79129.99316.20
2.282.0312.9143.9637.58-1.66209.79
2.364.478.729.6332.0573.59249.49
1.987.2626.2828.6974.71121.86307.57
-0.381.5515.788.1921.2648.48174.80
-6.69-8.588.0119.7678.61103.41413.56
3.8117.6136.6735.1999.49129.68197.73
4.6817.8015.5513.7836.2870.6370.63
1.6611.0127.9751.7388.07117.63163.79
4.0315.3213.9517.1262.1853.67230.51
2.927.0015.065.7328.3057.34230.27
1.1617.7443.7883.19124.08221.19342.26
-4.262.089.9928.4597.4283.19133.66
-0.84-2.279.2627.8736.45-0.8455.20
1.2330.2332.0543.4083.27112.81374.80
-2.575.715.6114.6553.8610.20191.55
-2.46-8.66-0.315.0617.75-52.311.84
1.342.7711.1026.2337.83131.07944.10
0.6910.9728.8729.4855.223.92105.57

Concord Biotech Ltd. Share Holdings

Concord Biotech Ltd. Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested
(in ₹ crore)
DSP Healthcare Fund6,24,5693.72102.45
Baroda BNP Paribas Multi Cap Fund1,99,3591.2232.7
Bandhan Core Equity Fund1,54,3640.4225.32
Nippon India Pharma Fund1,49,4380.324.51
Bandhan Midcap Fund91,8131.0315.06
UTI Healthcare Fund80,0001.2113.12
HSBC Flexi Cap Fund77,6530.2612.74
Baroda BNP Paribas ELSS Tax Saver Fund66,5001.1510.91
Nippon India Nifty Smallcap 250 Index Fund30,1120.294.94
ITI Balanced Advantage Fund28,2491.214.63
View All Mutual Funds

Concord Biotech Ltd. Corporate Actions

Announcement
Board Meetings
Dividend
  • Concord Biotech Ltd. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
    The transcripts of the earning calls for the first quarter ended June 30, 2024 is enclosed herewith.kindly take the same into your records.
    20-Aug, 2024 | 04:10 PM
  • Concord Biotech Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated August 07, 2024 to the Stock exchanges regarding Earning call in respect of the unaudited (Standalone and Consolidated) Financial Results of the company for the First Quarter ended on June 30, 2024, we wish to inform that the said Earning Call was held today at 03:30 PM (IST).Kindly take the above on records.
    12-Aug, 2024 | 05:01 PM
  • Concord Biotech Ltd. - Announcement under Regulation 30 (LODR)-Investor Presentation
    Pursuant to Regulation 30 of SEBI (LODR) Regulation 2015, Investor Presentation on financial results for the first quarter ended June 30, 2024, is enclosedKindly take the above on records
    10-Aug, 2024 | 05:50 PM
  • Concord Biotech Ltd. - Financial Results For 30/06/2024
    Unaudited Standalone and Consolidated Financial Statement for the first quarter ended june 30, 2024
    09-Aug, 2024 | 01:41 PM
  • Concord Biotech Ltd. - Board Meeting Outcome for Outcomes Of Board Meeting For The Unaudited Financials Results For The First
    With reference to the intimation of Board meeting submitted on July 31, 2024, we would like to informyou that the Board of Directors of the Company, at its meeting held today i.e. Friday, August 09, 2024,has inter-alia, approved Unaudited Standalone and Consolidated Financial Results for the First quarterended on June 30, 2024. The said results were also reviewed by the Audit Committee of the Company inits meeting held on August 09, 2024.
    09-Aug, 2024 | 12:34 AM

About Concord Biotech Ltd.

Pharmaceuticals

Management

  • Mr. Ankur Vaid
    Joint Managing Director & CEO
  • Mr. Ravi Kapoor
    Non Executive Director
  • Mr. Rajiv Ambrish Agarwal
    Non Executive Director
  • Mrs. Bharti Khanna
    Independent Director
  • Mr. Amitabh Thakore
    Independent Director
  • Mr. Arvind Agarwal
    Independent Director
  • Mr. Jayaram Easwaran
    Independent Director
  • Dr. Mandayam Chakravarthy Sriraman
    Independent Director

FAQs on Concord Biotech Ltd.

What is the Market Cap of Concord Biotech Ltd.?

The market cap of Concord Biotech Ltd. is ₹16,697.79 Cr as on Aug 29, 2024.

What is the PE and PB Ratio of Concord Biotech Ltd.?

P/E ratio of Concord Biotech Ltd. is 54.2 and PB ratio of Concord Biotech Ltd. is 10.94 as on Aug 29, 2024.

What is the share price of Concord Biotech Ltd.?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Concord Biotech Ltd. is ₹1,707.00 as on Aug 29, 2024.

What are the 52 Week High and 52 Week Low of Concord Biotech Ltd.?

The 52-week high/low is the highest and lowest price at which Concord Biotech Ltd. stock has traded in the past 52-week or nearly a year. The 52-week high of Concord Biotech Ltd. is ₹1,793.50 and 52-week low of Concord Biotech Ltd. is ₹952.05 as on Aug 29, 2024.

icon
Market Data